UK markets closed

Eliem Therapeutics, Inc. (ELYM)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
8.29+0.54 (+6.97%)
At close: 04:00PM EDT
8.14 -0.15 (-1.81%)
After hours: 07:12PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-14,526
-35,119
-45,244
-47,480
-20,668
Stock-based compensation
3,100
12,806
6,991
3,737
707
Change in working capital
5,582
3,764
210
-4,172
-2,936
Accounts payable
-780
-686
-653
318
-24
Other working capital
-7,241
-20,599
-37,369
-36,072
-14,098
Other non-cash items
371
405
443
11,718
9,158
Net cash provided by operating activities
-7,241
-20,599
-37,369
-36,072
-14,098
Cash flows from investing activities
Purchases of investments
-40,997
-58,449
-87,963
-114,970
0
Sales/maturities of investments
117,932
127,430
122,403
0
-
Other investing activities
-
-
-
-
8,078
Net cash used for investing activities
76,935
68,981
34,440
-114,970
8,078
Cash flows from financing activities
Common stock issued
-
-
0
83,144
0
Net cash used provided by (used for) financing activities
855
841
0
177,232
4,925
Net change in cash
70,594
49,527
-3,337
26,435
-736
Cash at beginning of period
34,437
43,585
46,922
20,487
21,223
Cash at end of period
104,986
93,112
43,585
46,922
20,487
Free cash flow
Operating cash flow
-7,241
-20,599
-37,369
-36,072
-14,098
Free cash flow
-7,241
-20,599
-37,369
-36,072
-14,098